Psychologists in Springfield, PA Accepting Medicare

37 Psychologists found. Showing 1 - 20

Mark D Cassano Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 1260 E Woodland Ave Ste 200, Springfield, PA 19064 Phone: 610-690-4490

Fred B Mckinney, PH.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 1489 Baltimore Pike, Building 200 Suite 250, Springfield, PA 19064 Phone: 610-544-2110

Elizabeth Ann Merryfield, PSYD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1489 Baltimore Pike, Springfield, PA 19064 Phone: 610-544-2110

Dr. Tamar Halpern, PSY.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 1489 Baltimore Pike Ste 250, Springfield, PA 19064 Phone: 610-544-2110

Dr. Lara Lucine Nalbandian, PSY.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 1489 Baltimore Pike, Bldg. 200, Ste. 250, Springfield, PA 19064 Phone: 610-544-2110

Dr. Karen L Kampmeyer, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 133 Wood Rd, Springfield, PA 19064 Phone: 610-745-9676

Daniel Scullington Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1489 Baltimore Pike Ste 250, Springfield, PA 19064 Phone: 610-544-2110

Dr. Christopher Thomas Kaczka, PSY.D. Psychologist Medicare: Medicare Enrolled Practice Location: 1489 Baltimore Pike Ste 250, Springfield, PA 19064 Phone: 610-544-2110

Dr. Denise Rhylva Jakob, PSY.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 1489 Baltimore Pike, Bldg 200 - Suite 250, Springfield, PA 19064 Phone: 610-544-2110

Dr. Lauren Susan Lineback, PSYD Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 1489 Baltimore Pike, Suite 250, Springfield, PA 19064 Phone: 610-544-2110

John Logan Durland Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 1489 Baltimore Pike Ste 250, Springfield, PA 19064 Phone: 610-544-2110

Linda Molmen Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 1489 Baltimore Pike, Springfield, PA 19064 Phone: 610-544-2110

Dr. Robert Peter Petruzzi, PH.D. Psychologist - Cognitive & Behavioral Medicare: Accepting Medicare Assignments Practice Location: 1489 Baltimore Pike, Bldg. 200, Suite 250, Springfield, PA 19064 Phone: 610-544-2110    Fax: 610-604-9510

Dr. Vincent John Bellwoar, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1489 Baltimore Pike, Suite 250, Springfield, PA 19064 Phone: 610-544-2110    Fax: 610-604-9510

Dr. Karen Gale Haber, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 1489 Baltimore Pike, Suite 250, Springfield, PA 19064 Phone: 610-544-2110    Fax: 610-604-9510

Dr. Earl Eugene Delong, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 1489 Baltimore Pike, Springfield, PA 19064 Phone: 610-544-2110

Dr. Zachary Maichuk, PSYD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1489 Baltimore Pike, Bldg. 200, Suite 250, Springfield, PA 19064 Phone: 610-544-2110

Dr. Christine Mcginnis, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1489 Baltimore Pike, Bldg. 200, Suite 250,, Springfield, PA 19064 Phone: 610-544-2110

Dr. Adam Scott Lemisch, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1489 Baltimore Pike Ste 250, Springfield, PA 19064 Phone: 610-544-2110    Fax: 610-604-9510

Dr. Julie Diane Thompson, PSYD Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 1489 Baltimore Pike Ste 250, Springfield, PA 19064 Phone: 610-544-2110

News Archive

Abbvie presents venetoclax Phase 1 results in patients with multiple myeloma at ASCO 2015

AbbVie, a global biopharmaceutical company, today announced that results from a Phase 1b trial of investigational venetoclax, a novel inhibitor of the B-cell lymphoma-2 (BCL-2) protein that is being developed in partnership with Genentech and Roche, in combination with bortezomib and dexamethasone, showed an 83 percent overall response rate (n=5/6) in bortezomib-naive patients with relapsed/refractory (R/R) multiple myeloma, including two patients who achieved complete responses.1 These data will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on Sunday, May 31, in Chicago.

Cases of two AIDS patients renew hope of AIDS cure for many scientists, New York Times reports

The New York Times profiles two AIDS patients whose cases "suggest to many scientists that curing AIDS may be achievable," according to the newspaper. "One man, the so-called Berlin patient, apparently has cleared his HIV infection, albeit by arduous bone marrow transplants," and the other, "a 50-year-old man in Trenton, N.J., underwent a far less difficult gene therapy procedure. While he was not cured, his body was able to briefly control the virus after he stopped taking the usual antiviral drugs, something that is highly unusual," the newspaper writes.

Study sheds light on when to start antiretroviral therapy

Findings from a study published in the current issue of the journal Archives of Internal Medicine, when "taken together with other studies published over the last few years," show that beginning people living with HIV on highly active antiretroviral therapy (HAART) when their CD4 cell count is between 350 and 500 "appears to be beneficial over the long term.

Type 2 diabetes explosion in Australia predicted

Health loss caused by type 2 diabetes will more than double in Australia by 2023, as health loss from most other major causes falls, according to new research by The University of Queensland's (UQ) School of Population Health.

Read more Medical News

› Verified 2 days ago

• 1(current)
• 2